• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Dr. Reddy's Laboratories Ltd.
    09 Jul 2025
    1261.00
    0.63%
    Dr Reddy's Labs Dividend: Last Day To Buy Shares And Qualify Before Record Date
    Dr Reddy's Labs Dividend: Last Day To Buy Shares And Qualify Before Record Date
    NDTV Profit
    Dr Reddy's Labs will pay a final dividend of Rs 8 per share for the financial year 2025.
    Copy LinkShare onShare on Share on Share on
    Dr. Reddy's Laboratories Ltd.'s price crossed below 50Day SMA today
    Dr. Reddy's Laboratories shares to go ex-dividend tomorrow. Do you own?
    Economic Times | 09 Jul 2025
    logo
    Dr. Reddy's Laboratories Ltd.
    08 Jul 2025
    1261.00
    0.63%
    Trump Tariffs: Dr Reddy's To Lupin Pharma Stocks To Be In Focus After Threat Of 200% Levies
    Trump Tariffs: Dr Reddy's To Lupin Pharma Stocks To Be In Focus After Threat Of 200% Levies
    NDTV Profit
    Trump's threat of 200% tariff on pharmaceutical products could have severe implications on Indian drugmakers, as exports to the US form a significant share of their overall sales.
    Copy LinkShare onShare on Share on Share on
    Dr. Reddy's Laboratories Ltd.'s price crossed below 50Day SMA today
    logo
    Nectar Lifesciences Ltd.
    08 Jul 2025
    14.42
    -2.04%
    Nectar Lifesciences hits 52-week low; why are investors dumping stock?
    Business Standard
    Nectar Lifesciences share price hit 52-weel low at 18.6 per share; here's why the stock is under pressure
    Copy LinkShare onShare on Share on Share on
    Nectar Lifesciences Ltd. has lost -37.17% in the last 6 Months
    logo
    Nectar Lifesciences Ltd.
    08 Jul 2025
    14.42
    -2.04%
    Nectar to sell API, formulations and menthol biz to Ceph for 1,290 cr
    Business Standard
    Nectar Lifesciences Ltd on Tuesday said it will sell its active pharmaceutical ingredients and formulation along with menthol business assets to Ceph Lifesciences Pvt Ltd, for Rs 1,290 crore. The company has signed a definitive Business Transfer Agreement (BTA) for the sale of its core business division, comprising the manufacture, distribution, and marketing of Active Pharmaceutical Ingredients (APIs) and formulations to Ceph Lifesciences for Rs 1,270 crore on a slump sale basis, Nectar said in a regulatory filing. Additionally, the company has entered into an Asset Purchase Agreement (APA) for the sale of its menthol business assets to Ceph Lifesciences for Rs 20 crore, marking a comprehensive restructuring move aligned with its future strategy, it added. "By divesting mature segments of our business, we are laying the foundation for a focused and agile organisation geared towards innovation and long-term value creation," Nectar Lifesciences Promoter and Chairman Sanjiv Goyal...
    Copy LinkShare onShare on Share on Share on
    Nectar Lifesciences Ltd. has lost -64.80% in the last 1 Year
    logo
    Pfizer Ltd.
    08 Jul 2025
    4978.00
    0.95%
    Dividend stocks: Pfizer, 6 others to go ex-date on July 9; do you own any?
    Business Standard
    Here is the complete list of stocks that will trade ex-dividend on July 9, following their announcements of dividend rewards for shareholders
    Copy LinkShare onShare on Share on Share on
    Pfizer Ltd. is trading below its 30 day SMA of 5239.0
    logo
    Sun Pharmaceutical Industries Ltd.
    07 Jul 2025
    Tariff Impact
    1617.00
    1.91%
    Sun Pharma says working towards full regulatory resolution at 3 plants facing USFDA action
    Business Line
    The company is facing an import alert for the Halol facility and also is in receipt of non-compliance letter for the Mohali facility
    Copy LinkShare onShare on Share on Share on
    Sun Pharmaceutical I.. has an average target of 2050.25 from 8 brokers.
    logo
    Solara Active Pharma Sciences Ltd.
    06 Jul 2025
    624.50
    1.50%
    Solara Active Pharma Sciences: A Strategic Shift Towards High-Value Growth
    Solara Active Pharma Sciences: A Strategic Shift Towards High-Value Growth
    NDTV Profit
    Copy LinkShare onShare on Share on Share on
    Solara Active Pharma Sciences Ltd.'s price crossed below 50Day SMA today
    logo
    Emcure Pharmaceuticals Ltd.
    04 Jul 2025
    1277.10
    -0.55%
    Emcure Pharmaceuticals Bulk Deal: BC Investments Offloads Stake For Rs 563 Crore
    Emcure Pharmaceuticals Bulk Deal: BC Investments Offloads Stake For Rs 563 Crore
    NDTV Profit
    The public shareholder sold the 2.37% stake for Rs 1,250.44 apiece.
    Copy LinkShare onShare on Share on Share on
    Emcure Pharmaceuticals Ltd. is trading below its 30 day SMA of 1388.6
    Emcure Pharma shares dip after 2.4% stake change hands in block trades
    Business Standard | 04 Jul 2025 1 more
    Emcure Pharma Block Deal: Public Shareholder BC Investments To Sell 2.4% Stake
    NDTV Profit | 03 Jul 2025
    logo
    Sun Pharmaceutical Industries Ltd.
    04 Jul 2025
    Tariff Impact
    1617.00
    1.91%
    Price pressures to intensify for drugmakers, says Sun Pharmaceutical
    Business Standard
    Sun Pharma expects global pricing strain due to policy shifts, as FY25 US sales rise 5.8% despite compliance challenges; specialty business lifts overall growth
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 1351 to 1326 in Jun 2025 qtr
    logo
    Lupin Ltd.
    04 Jul 2025
    1953.80
    1.77%
    Lupin launches nasal spray in US, part of 200-drug pipeline by FY30
    Business Standard
    The product, launched in the US market, is a generic version of Atrovent and part of Lupin's plan to scale complex generics revenue share to 62 per cent by FY30
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 979 to 987 in Jun 2025 qtr.
    Lupin launches generic Ipratropium Bromide nasal spray in US market
    Business Line | 04 Jul 2025
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • Jinkushal Industries
    • Chatterbox Technologies
    • Rukmani Devi Garg Agro Impex
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd (RA SEBI Reg No: INH000022507)